158 related articles for article (PubMed ID: 30204129)
1. HIC1 deletion promotes breast cancer progression by activating tumor cell/fibroblast crosstalk.
Wang Y; Weng X; Wang L; Hao M; Li Y; Hou L; Liang Y; Wu T; Yao M; Lin G; Jiang Y; Fu G; Hou Z; Meng X; Lu J; Wang J
J Clin Invest; 2018 Dec; 128(12):5235-5250. PubMed ID: 30204129
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer.
Sun X; Qu Q; Lao Y; Zhang M; Yin X; Zhu H; Wang Y; Yang J; Yi J; Hao M
BMC Cancer; 2019 Dec; 19(1):1180. PubMed ID: 31795965
[TBL] [Abstract][Full Text] [Related]
3. HIC1 loss promotes prostate cancer metastasis by triggering epithelial-mesenchymal transition.
Hao M; Li Y; Wang J; Qin J; Wang Y; Ding Y; Jiang M; Sun X; Zu L; Chang K; Lin G; Du J; Korinek V; Ye DW; Wang J
J Pathol; 2017 Aug; 242(4):409-420. PubMed ID: 28466555
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer.
Katara GK; Kulshrestha A; Schneiderman S; Riehl V; Ibrahim S; Beaman KD
Mol Oncol; 2020 Jan; 14(1):211-224. PubMed ID: 31725949
[TBL] [Abstract][Full Text] [Related]
5. Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression.
Wu T; Wang W; Shi G; Hao M; Wang Y; Yao M; Huang Y; Du L; Zhang X; Ye D; Bian X; Wang J
Cell Death Dis; 2022 Jul; 13(7):624. PubMed ID: 35853880
[TBL] [Abstract][Full Text] [Related]
6. Study on the mechanism of heterogeneous tumor-associated macrophages in three subtypes of breast cancer through the integration of single-cell RNA sequencing and in vitro experiments.
Yuan Y; Zhang S; Huang J
Mol Biol Rep; 2024 Jun; 51(1):720. PubMed ID: 38824268
[TBL] [Abstract][Full Text] [Related]
7. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
[TBL] [Abstract][Full Text] [Related]
8. A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours.
Fu R; Han CF; Ni T; Di L; Liu LJ; Lv WC; Bi YR; Jiang N; He Y; Li HM; Wang S; Xie H; Chen BA; Wang XS; Weiss SJ; Lu T; Guo QL; Wu ZQ
Nat Commun; 2019 Jul; 10(1):3210. PubMed ID: 31324807
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
Li P; Liu X; Dong ZM; Ling ZQ
Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
[TBL] [Abstract][Full Text] [Related]
10. The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).
Foveau B; Boulay G; Pinte S; Van Rechem C; Rood BR; Leprince D
J Biol Chem; 2012 Feb; 287(8):5366-78. PubMed ID: 22184117
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
12. BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation.
Pickup MW; Hover LD; Polikowsky ER; Chytil A; Gorska AE; Novitskiy SV; Moses HL; Owens P
Mol Oncol; 2015 Jan; 9(1):179-91. PubMed ID: 25205038
[TBL] [Abstract][Full Text] [Related]
13. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
14. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y
Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
[TBL] [Abstract][Full Text] [Related]
15. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.
Xu K; Tian X; Oh SY; Movassaghi M; Naber SP; Kuperwasser C; Buchsbaum RJ
Breast Cancer Res; 2016 Jan; 18(1):14. PubMed ID: 26821678
[TBL] [Abstract][Full Text] [Related]
16. Mechano-Signal Transduction in Mesenchymal Stem Cells Induces Prosaposin Secretion to Drive the Proliferation of Breast Cancer Cells.
Ishihara S; Inman DR; Li WJ; Ponik SM; Keely PJ
Cancer Res; 2017 Nov; 77(22):6179-6189. PubMed ID: 28972074
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of RARβ inhibits Wnt1-induced mammary tumorigenesis by suppressing epithelial-mesenchymal transitions.
Liu X; Giguère V
Nucl Recept Signal; 2014; 12():e004. PubMed ID: 25422594
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB.
Okita Y; Kimura M; Xie R; Chen C; Shen LT; Kojima Y; Suzuki H; Muratani M; Saitoh M; Semba K; Heldin CH; Kato M
Sci Signal; 2017 Apr; 10(474):. PubMed ID: 28400538
[TBL] [Abstract][Full Text] [Related]
19. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
